CLINICAL ROLE -
NASP President Speaks About PBM Regulation and DIR Fees
Rebecca Shanahan, JD, chief executive officer of Avella Specialty and president of the National Association of Specialty Pharmacy discusses how legislation can impact direct and indirect remuneration fees.
Read More
Pharmaceutical Pollution on the Rise
Unsafe drug manufacturing facilities give rise to multidrug-resistant bacteria.
NASP Strikes Back at DIR Fee Study Claiming Cost Savings for Medicare
National Association of Specialty Pharmacy states that direct and indirect remuneration fees increase drug costs for seniors.
Moderate Alcohol Intake Linked to Healthy Brain Aging
Elderly patients who regularly consumed alcohol found less likely to develop dementia.
FDA Advisory Panel Votes in Favor of Investigational Hepatitis B Vaccine
Heplisav-B aims to boost a patient’s own immune response to fight off HBV.
Diabetes Rates Spike Among Younger Adults
Findings highlight the need for interventions that target obesity in adults aged 18 to 34.
Scientists Reach Breakthrough in Rare Lymphoma
Two mutations may cause angioimmunoblastic T cell lymphoma.
Mortality Rate Doubles for Patients with Depression, Heart Disease
Developing depression after a diagnosis of coronary heart disease is a large predictor of death.
Backing Up: Addressing Adherence Barriers in COPD
Patients with chronic obstructive pulmonary disease (COPD) often have difficulty adhering to medications, leading to exacerbations, and often hospitalization.
Novel Stem Cell Therapy Harnesses Herpes Virus to Attack Melanoma
Stem cells carrying oncolytic herpes simplex virus effective against cancer that has metastasized to the brain.
Investigational HIV Vaccine Effective, Well-Tolerated Among Patients
Mosaic vaccines observed to bolster immune response against HIV.
Trending News Today: Jury Convicts Notorious Price-Gouger Martin Shkreli
Top news of the day from across the health care landscape.
HIV-Specific Broadly Neutralizing Antibody Minimally Impacts Time to Viral Rebound Following ART Interruption
The study is the first to evaluate VRC01 antibody in patients who started antiretroviral therapy during acute HIV infection.
Pharmaceutical Care Improves Outcomes in Patients With HIV
Pharmacist intervention on drug-related problems in HIV outpatients can alleviate adherence issues.
Trending News Today: Affordable Care Act Uncertainty Could Raise Premiums
Top news of the day from across the healthcare landscape.
FDA Updates Labeling for OIC Medication
Most patients on opioids experience one if not more adverse events, many gastrointestinal, during the course of therapy.
The Unusual Discovery of Commonly Prescribed Medications: Part 3
This article will describe the unusual discovery of 5 commonly prescribed medications, many of which were through serendipitous events.
4 Things Pharmacists Should Know About Eculizumab and Meningococcal Disease
Eculizumab is an injection that is associated with an increased risk of meningococcal disease.
A Conference for those Looking for a Nontraditional Pharmacy Career
When I first interviewed a pharmacist about her pharmacy position for my column, I found what I was meant to do and what I love to do: tell stories.
PBMs Release 2018 Formulary Lists Tops AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
EU Approves Pan-Genotypic Drug for Chronic Hepatitis C Virus
Maviret is an 8-week treatment that combines 2 distinct antiviral agents.
Judge Issues Injunction Against Pharmacy Company
Isomeric allegedly manufactured and distributed purportedly sterile drug products, including injectable and ophthalmic drugs that were adulterated because the drugs were made under insanitary conditions.
DEA Proposes Reducing Opioid Manufacturing for 2018
Officials with the US Drug Enforcement Administration (DEA) have proposed to cut the amount of controlled substances to be manufactured in 2018 by 20%, compared to 2017, according to a press release.
NASP President Discusses How Organization Works to Combat DIR Fees
Rebecca Shanahan, JD, chief executive officer of Avella Specialty and president of the National Association of Specialty Pharmacy speaks about DIR fees in a 3-part interview.
Experimental Drug May Normalize Brain Function in Alzheimer's Disease
BACE inhibitors observed to reduce amyloid production and accumulation in the brain.
Diabetes Self-Management Education and Support Guidelines Released
The American Diabetes Association and the American Association of Diabetes Educators report seeks to improve self-care and management of the chronic condition.
FDA Drug Approvals Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
FDA Advisory Committee Backs Pending Approval of Xeljanz to Treat Psoriatic Arthritis
If approved, Xeljanz will be the first Janus kinase inhibitor for psoriatic arthritis.
Reported Cases of HIV-Infection Increases 140% in Philippines
Pilot project to bring pre-exposure prophylaxis to the Philippines for the first time.
Pharmacy Week in Review: August 4, 2017
A look at last week's top stories in the world of pharmacy.
Watch